2011
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor. The... |
2008
|
Invention
|
Combinations comprising antimuscarinic agents and pde4 inhibitors.
A combination which comprises... |
|
Invention
|
Quinuclidine amide derivatives. New quinuclidine amide derivatives having the chemical structure ... |
2007
|
Invention
|
Inhalation device for drugs in powder form. To provide an inhalation device which has improved us... |
|
Invention
|
Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors. A compound of formula (I) ... |
|
Invention
|
Substituted pyrimidines as adenosine receptor antagonists. Compounds of formula (I) including pha... |
|
Invention
|
5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b aden... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor.
Th... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor. T... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor. T... |
|
Invention
|
1,7-naphthyridine derivatives as p38 map kinase inhibitors. New inhibitors of the p38 mitogen-act... |
|
Invention
|
1, 7-naphthyridine derivatives as p38 map kinase inhibitors. This invention is directed to new in... |
|
Invention
|
Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabi... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor.
This ... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the &bgr;2 adrenergic receptor. Th... |
|
Invention
|
New pyridin-3-amine derivatives.
This invention is directed to new inhibitors of the p38 mitogen... |
|
Invention
|
New pyridin-3-amine derivatives. This invention is directed to new inhibitors of the p38 mitogen-... |
|
Invention
|
Phenoxy-substituted pyrimidines as adenosine receptor antagonists. Compounds of formula (I), incl... |
|
Invention
|
New pyrrolidinium derivatives.
New pyrrolidinium derivatives having the chemical structure of g... |
2006
|
Invention
|
2b adenosine receptor antagonists. The present disclosure relates to imidazopyridine derivatives ... |
|
Invention
|
Imidazopyridine derivatives as a2b adenosine receptor antagonists. New imidazopyrdidine derivativ... |
|
Invention
|
Pyrazine derivatives useful as adenosine receptor antagonists. The present disclosure relates to ... |
|
Invention
|
Pyrazine derivatives useful as adenosine receptor antagonists. The present invention provides a c... |
|
Invention
|
Pyrido[3' ,2':4,5]furo[3,2-d]pyrimidine derivatives.
The present disclosure relates to a pyridof... |
|
Invention
|
New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives. The present invention provides a pyridofu... |
|
Invention
|
New pyrido⏧3',2':4,5]furo⏧3,2-d]pyrimidine derivatives. The present invention... |
|
Invention
|
Tablets with improved dissolution profile.
The present disclosure relates to tablets obtainable ... |
|
Invention
|
Tablets with improved dissolution profile. The invention relates to tablets obtainable by compres... |
|
Invention
|
N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists.
New antagonists of the i... |
|
Invention
|
N-amide derivatives of 8-azabicyclo⏧3.2.1]oct-3-yl as ccr1 antagonists. The present inventio... |
|
Invention
|
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the &bgr;2 adrenergic receptor. Th... |
|
Invention
|
Combinations comprising antimuscarinic agents and beta-adrenergic agonists.
Combinations compris... |
|
Invention
|
Combinations comprising antimuscarinic agents and corticosteroids.
Combinations comprising (a) a... |
|
Invention
|
2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists. Compounds of formul... |
2005
|
Invention
|
Process for preparing quinuclidinium carbamate derivatives.
A new process for preparing carbamat... |
|
Invention
|
Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors.
The invention relates to new t... |
|
Invention
|
H)-one derivatives and their use as pde4 inhibitors. The invention relates to new therapeutically... |
|
Invention
|
Combinations comprising antimuscarinic agents and corticosteroids.
The present invention provid... |
|
Invention
|
Combinations comprising antimuscarinic agents and beta-adrenergic agonists.
The present inventi... |
|
Invention
|
Condensed pyridine derivatives useful as a2b adenosine receptor antagonists.
New antagonists of ... |
|
Invention
|
Quaternized quinuclidine esters.
Compounds of formula (I)
Compounds of formula (I)
... |
2004
|
Invention
|
Non-tabletted, chewable, individually dosed administration forms.
Non-tabletted, individually do... |
|
Invention
|
Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors. New pyridazin-e-(2H)-one deriva... |
|
Invention
|
Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists.
This inventio... |
|
Invention
|
2,3'-bipyridines derivatives as selective cox-2 inhibitors.
The present invention relates to 2,... |
|
Invention
|
3-phenylfuran-2-one derivatives as cox-2 inhibitor.
The present invention relates to 3-phenylfu... |
|
Invention
|
4-aminothieno[2,3-d]pyrimidine-6-carbonitrile derivatives as pde7 inhibitors. New 4-aminothieno[2... |